Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection
about
IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino SinusitisImportant Role of the IL-32 Inflammatory Network in the Host Response against Viral InfectionHepatitis B virus inhibits apolipoprotein A5 expression through its core geneGene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial InfarctionInterleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.An overview of the highly pathogenic H5N1 influenza virus.Construction of the influenza A virus infection-induced cell-specific inflammatory regulatory network based on mutual information and optimizationInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Genetic signature of strong recent positive selection at interleukin-32 gene in goat.Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitisChungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanismInterleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.Clinical aspects and cytokine response in adults with seasonal influenza infectionIL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signalingTherapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells.Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1.IL-32-dependent effects of IL-1beta on endothelial cell functionsInducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1)Molecular characterization of IL-32 in human endothelial cellsSoluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Novel insights into the biology of interleukin-32.Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity.Influenza A virus upregulates PRPF8 gene expression to increase virus production.Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability.Inducible TAP1 Negatively Regulates the Antiviral Innate Immune Response by Targeting the TAK1 Complex.Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway.Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection.
P2860
Q26753017-60437D6F-8528-4F2E-A9A3-12DB34005B58Q26826958-4324F9AB-E814-4824-BFA6-BEB5E693E30FQ28597775-F39061B9-B190-47CD-98E8-0681CD47EE02Q30371815-CE6CAC38-11F0-4F7D-A0A1-99A33202E9DEQ30411120-DE77D353-4E0F-47D8-8095-BAEB901EAB6FQ30426011-FE19AB7B-C2B2-4AE3-B77F-4A9AC83FC13FQ33592810-2AD98E25-15C2-4F18-A4A9-B1F353319710Q33633481-923A05DB-A0EA-4856-BA24-7419FDC63EC9Q33866628-679939BA-328A-46BE-BCF2-959F984EF2C7Q34124598-BBBF475E-4537-45F2-9CA2-934044411FE5Q34437388-DCE5DA47-1229-48E7-B447-8D496F8D8EE2Q34483769-6D6B6CDA-2488-476A-9842-B7C8399A675EQ35017312-8DBE5202-7134-4776-A90C-74D5CF0DD7A2Q35469357-30C3FBE8-F3A1-4382-A32D-7BA7548D99D6Q35641151-B17CE0A7-169C-4D87-BEEF-B06D0E8BD768Q35665775-0D444704-13AF-4949-A4F8-BA40FC62ABA6Q35874404-B6FEA829-DD7A-4624-BA20-E5B5E0997A27Q35947673-533F9A35-1294-4231-B387-EFC185C19889Q35948586-1D9F9D39-472A-45FF-AB5D-BCA73D57222FQ36085075-AE7D0FDE-C17B-40BC-AEB9-23097705418BQ36155931-1F6B7482-A075-4E16-960E-9ED2EE9C7701Q36291428-9073CFCB-C266-4F67-A00C-32211E64FC80Q36611248-11B356C5-E41C-491D-AD78-B3BFF85C5C28Q36686444-6CE80D40-BDBC-442E-ACCD-34D5AC89186DQ36922908-D42C9AE5-D30E-4F7B-A51A-6DEEA0E92E8DQ37129422-CD5B38C6-2E54-4CE4-A8FB-D6ACB88EE8CBQ37175095-5F5BB906-5172-4918-81DC-BDD09BF81A75Q37248214-9DFE49DA-6C80-48EB-9D86-765EC92F76EAQ37252579-D94DF17F-F70A-4BB0-B4A7-6B8FC513B8A9Q37257891-B6EE3A31-A39F-4D94-BFB4-C880AF4D731DQ37584726-2C41AA38-6547-4142-B4C4-B078D524EBEBQ38086768-3DA137E0-9EF3-4A18-BD04-F616DAD48F05Q38502773-DD91664F-689F-4C00-9A2D-6487B37C8070Q38720116-5CCE28D3-B6B0-4EA4-8317-542E20F2D435Q39580319-4BFEB8A8-9295-41FF-8CA2-86A748F1F825Q39611935-5FDD6ABA-A76E-47CA-9814-119548DD8959Q39707624-F646C560-A188-4FA2-9646-7F5689B2E175Q40268002-31553FD0-74F3-4C40-80A9-0FE75AB08E39Q40621223-4BFC5A5C-6BCC-4AA1-BC65-2554CEF7E6D1Q40699208-D5A4D685-1E13-4399-BBE3-06EE042940BC
P2860
Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Activation of interleukin-32 p ...... to influenza A virus infection
@ast
Activation of interleukin-32 p ...... to influenza A virus infection
@en
Activation of interleukin-32 p ...... to influenza A virus infection
@nl
type
label
Activation of interleukin-32 p ...... to influenza A virus infection
@ast
Activation of interleukin-32 p ...... to influenza A virus infection
@en
Activation of interleukin-32 p ...... to influenza A virus infection
@nl
prefLabel
Activation of interleukin-32 p ...... to influenza A virus infection
@ast
Activation of interleukin-32 p ...... to influenza A virus infection
@en
Activation of interleukin-32 p ...... to influenza A virus infection
@nl
P2093
P2860
P3181
P1433
P1476
Activation of interleukin-32 p ...... to influenza A virus infection
@en
P2093
Guiqing Peng
Jianguo Wu
Muhammad Mahmood Mukhtar
Yanni Chen
P2860
P3181
P356
10.1371/JOURNAL.PONE.0001985
P407
P577
2008-04-16T00:00:00Z